Yvonne Bryson, M.D., an infectious disease researcher at UCLA, presented the case of an American woman who was cured of HIV after receiving a new transplant procedure that leverages donated umbilical cord blood.
Precision Medicine Study Points to Promising New Approach in Alzheimer’s
Alzheimer’s disease, Biomarkers, Buck Institute for Research on Aging, Clinical Studies, Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, Early-stage dementia, Eli Lilly, Los Angeles (UCLA), Mild Cognitive Impairment (MCI), Precision Medicine, R&DAlzheimer’s disease is the holy grail of pharmaceutical research, and a team of physicians published results showing that they may have found the key to actually improving cognition in patients with early-stage dementia.
According to a research collaboration among UCLA investigators and Merck KGaA, berzosertib has shown promise for Covid-19 and is also being touted for the drug’s unusually broad effect in treating a range of cancers.
Childhood vaccine linked to less severe Covid-19, cigarette smoke raises risk
AstraZeneca, Children, Cigarette smoke, Clinical Trials, Coronavirus Disease 2019 (COVID-19), COVID-19 Vaccines, Elderly, Immune System, Los Angeles (UCLA), Novel Coronavirus, R&D, Researchers, Severe Covid-19, The Lancet, Vaccines, Zika VirusA roundup of some of the latest scientific studies on the novel coronavirus includes research on whether a childhood vaccine may help prevent severe Covid-19 and whether cigarette smoke increases cell vulnerability to Covid-19.
A study published in the journal Cell Stem Cell revealed how aging can cause lung regeneration to go awry, which can potentially lead to lung cancer and other diseases.
Origin, a 3D printing specialist for medical devices, completed clinical trials and validation of the company’s 3D-printed nasopharyngeal swabs for use in COVID-19 test kits.
A smart insulin device under development could revolutionize how glucose levels are monitored in diabetes patients and deliver insulin doses when necessary.